Application of S-allyl-L-cysteine in preventing and treating radiotherapy injury

The invention provides application of S-allyl-L-cysteine in preventing and treating a radiotherapy injury. The medicine is used for preventing and/ or treating injuries caused by radiotherapy for malignant tumors, including nasopharynx cancer, esophagus cancer, gastric carcinoma, lung cancer, liver...

Full description

Saved in:
Bibliographic Details
Main Authors WANG YUANBO, ZHAO XIAOYAN, ZHAO BIN, SHANG ZHIMEI
Format Patent
LanguageChinese
English
Published 09.10.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention provides application of S-allyl-L-cysteine in preventing and treating a radiotherapy injury. The medicine is used for preventing and/ or treating injuries caused by radiotherapy for malignant tumors, including nasopharynx cancer, esophagus cancer, gastric carcinoma, lung cancer, liver cancer, breast cancer and the like, and is used for the cooperation function of tumor radiotherapy.Researches discover that the medicine can be used for effectively preventing and/ or treating the injuries caused by mice radiotherapy. The S-allyl-L-cysteine is hopefully developed into a radiotherapy injury protection medicine. 本发明提供了S-烯丙基-L-半胱氨酸在预防和治疗放疗损伤药物中的应用,所述药物是预防和/或治疗对鼻咽癌、食管癌、胃癌、肺癌、肝癌、乳腺癌等恶性肿瘤进行放射治疗所引起损伤的药物,并能用于肿瘤放疗的配合作用。本发明研究发现,所述药物能够有效的预防和/或治疗小鼠放射治疗所引起损伤。S-烯丙基-L-半胱氨酸有望开发成放疗损伤保护药物。
Bibliography:Application Number: CN20181651731